Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator I1234V mutation

Authors

• Atqah Abdul-Wahab, Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar. Tel. +97 (4) 4392834. Fax. +97 (4) 4439571. E-mail: atiqa{at}hmc.org.qa / atiqaaw{at}yahoo.com
• Ibrahim A. Janahi, Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar. Tel. +97 (4) 4392834. Fax. +97 (4) 4439571. E-mail: atiqa{at}hmc.org.qa / atiqaaw{at}yahoo.com
• Mohammed O. Abdel-Rahman, Department of Pediatrics, Hamad Medical Corporation, Doha, Qatar. Tel. +97 (4) 4392834. Fax. +97 (4) 4439571. E-mail: atiqa{at}hmc.org.qa / atiqaaw{at}yahoo.com

Article Type

Brief Report

First Page

1101

Last Page

1102

Recommended Citation

Abdul-Wahab, Atqah; Janahi, Ibrahim A.; and Abdel-Rahman, Mohammed O. (2009) "Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator I1234V mutation," Saudi Medical Journal: Vol. 30: Iss. 8, Article 22.
DOI: https://doi.org/10.15537/1658-3175.4811